Jeffrey Jones, M.D.

Jeffrey Jones, M.D.

Chief Medical OfficeratCullinan Therapeutics· In proxies 2023–2025

Pay in FY2025-34% from the year before · Cullinan Therapeutics stock -15.0% the same year

Jeffrey Jones, M.D. was paid $2.2M in FY2025 (Dec), down 34%. Cullinan Therapeutics stock fell 15.0% that year.

Pay$100 in the stock at the end of FY22 → $98
Pay is from the Summary Compensation Table of each Cullinan Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cullinan TherapeuticsPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role +60%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?